Manulife (Manufacturers Life Insurance)’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$375K Sell
55,824
-648
-1% -$4.36K ﹤0.01% 2290
2025
Q1
$511K Sell
56,472
-85
-0.2% -$768 ﹤0.01% 2132
2024
Q4
$978K Sell
56,557
-298
-0.5% -$5.15K ﹤0.01% 1919
2024
Q3
$909K Sell
56,855
-243
-0.4% -$3.88K ﹤0.01% 1971
2024
Q2
$814K Buy
57,098
+2,146
+4% +$30.6K ﹤0.01% 1960
2024
Q1
$779K Sell
54,952
-723
-1% -$10.2K ﹤0.01% 1987
2023
Q4
$840K Sell
55,675
-474
-0.8% -$7.15K ﹤0.01% 1886
2023
Q3
$887K Hold
56,149
﹤0.01% 1805
2023
Q2
$850K Buy
56,149
+8,437
+18% +$128K ﹤0.01% 1746
2023
Q1
$692K Buy
47,712
+6,506
+16% +$94.3K ﹤0.01% 1807
2022
Q4
$582K Buy
41,206
+31
+0.1% +$437 ﹤0.01% 1892
2022
Q3
$640K Hold
41,175
﹤0.01% 1825
2022
Q2
$532K Hold
41,175
﹤0.01% 2019
2022
Q1
$393K Buy
+41,175
New +$393K ﹤0.01% 2341